-
2022-502889-24-00
chemotherapy-induced polyneuropathy (CIPN) 2024-02-13
-
2024-516402-32-00
Adult patients with aHUS associated with HE and severe 2024-02-13
-
2023-504208-27-00
Community-acquired pneumonia 2024-02-12
-
2023-507295-40-00
Community-acquired pneumonia 2024-02-12
-
2023-503521-19-00
Duchenne muscular dystrophy (DMD) 2024-02-09
-
2024-515059-39-00
Marfan Syndrome
Diseases related to Marfan syndrome (ra 2024-02-09
-
2022-502707-29-00
Preeclampsia 2024-02-07
-
2023-506703-26-00
locally advanced rectal cancer 2024-02-07
-
2023-505687-11-00
Acute pain 2024-02-06
-
2023-506698-36-00
low-volume metastatic castration-sensitive prostate can 2024-02-02
-
2022-500862-93-00
Pulmonary Hypertension 2024-02-01
-
2022-502113-28-00
Follicular lymphoma 2024-02-01
-
2023-503327-26-00
Sjogren's syndrome 2024-01-31
-
2023-505028-74-00
Coronary artery disease 2024-01-29
-
2022-502980-39-00
Estrogen receptor (ER)-positive, HER2-negative advanced 2024-01-25
-
2023-506971-89-00
Coronary Artery Disease 2024-01-25
-
2023-506207-26-00
Heart failure with preserved ejection fraction (HFpEF) 2024-01-18
-
2024-511870-65-00
Adults Non Diabete Remission (NDR) Type 2 Diabete (T2D) 2024-01-16
-
2023-504322-19-00
Patients in the intensive care unit on ventilation with 2024-01-10
-
2022-503092-28-00
Relapsed/Refractory Follicular Lymphoma 2024-01-08
-
2022-502890-40-00
Destruction of kidney stones 2024-01-04
-
2023-503462-23-00
Lung transplant rejection 2023-12-28
-
2022-501858-11-00
Hemodynamic stable term and preterm neonates requiring 2023-12-26
-
2022-502046-28-00
HER2-Positive, PIK3CA Mutated, Locally Advanced or Meta 2023-12-22